How did harald zur Hausen discovered HPV?

How did harald zur Hausen discovered HPV?

Zur Hausen and his research team extracted HPV DNA from the tumor samples, and copied and amplified the HPV DNA in order to identify the strains. With the copied HPV DNA template matched to the HPV DNA in the tumor samples, zur Hausen and his colleagues could identify the types of HPV that caused genital warts.

Why harald zur hussain is famous?

listen); born 11 March 1936) is a German virologist and professor emeritus….

Harald zur Hausen
Born 11 March 1936 Gelsenkirchen, Germany
Known for Discovery that HPV can cause cervical cancer
Awards Ernst Jung Prize (1996) Prince Mahidol Award (2005) Nobel Prize in Physiology or Medicine (2008)
Scientific career

Who discovered HPV 16?

zur Hausen and his team found novel HPV- DNA in cervical cancer biopsies, thus discovering the tumorigenic virus type HPV 16 in 1983.

When was the human papillomavirus discovered?

As it turned out, another virus associated with cervical cancer would be the first definitively implicated: human papillomavirus, or HPV. The Times first mentioned HPV on Feb. 12, 1985. The report said that scientists, including Dr.

Who discovered HPV 18?

In 1983 and 1984 in Germany, physician Harald zur Hausen found that two HPV strains, HPV-16 and HPV-18, caused cervical cancer in women. In the early twenty first century, pharmaceutical companies Merck & Co.

What causes HPV virus?

HPV causes The virus that causes HPV infection is transmitted through skin-to-skin contact. Most people get a genital HPV infection through direct sexual contact, including vaginal, anal, and oral sex. Because HPV is a skin-to-skin infection, intercourse isn’t required for transmission to occur.

How long did it take to develop HPV vaccine?

In 1991, Frazer and Zhou’s findings were first presented to the scientific community. After seven years of design and testing, the first human trials for the vaccine, named Gardasil, were completed.

How long has HPV vaccine been around?

Since HPV vaccines were first introduced in the U.S. in 2006 there have been changes in the range of protection they offer and the dosing regimen.